{"favorite_id": 10321, "calc_type": "diagnostic_criteria", "dosing": false, "full_title_en": "Rome IV Diagnostic Criteria for Functional Biliary Sphincter of Oddi Disorder (SOD)", "short_title_en": "Rome IV for Biliary SOD", "medium_description_en": "Official Rome IV criteria for the diagnosis of functional biliary sphincter of Oddi disorder.", "short_description_en": "Biliary SOD diagnosis.", "before_use": "", "instructions_en": "<p dir=\"ltr\">Use in patients <strong>post-cholecystectomy</strong> with symptoms characteristic of typical biliary pain as defined by Rome IV criteria with elevated liver enzymes or dilated common bile duct, but NOT both. Supportive criteria such as normal amylase/lipase, abnormal sphincter of Oddi (SOD) manometry, or abnormal hepatobiliary scintigraphy can aid in diagnosis if available.</p>\n<p dir=\"ltr\">Do NOT use these criteria in patients with:</p>\n<p><span id=\"docs-internal-guid-18204329-7fff-51f9-9b8d-fb2b8758f1b6\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Atypical symptoms for biliary colic (mild, transient, constant, or daily pain).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Daily opiate use (can dilate bile ducts).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Structural diagnosis that explains symptoms (stones, pancreatitis, pancreatic or liver lesion).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">With neither dilated common bile duct nor elevated liver tests.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">With both dilated common bile duct and elevated liver tests.</p>\n</li>\n</ul>", "purpose_en": ["Diagnosis"], "disease_en": ["Sphincter of Oddi Disorders", "Gallbladder Disorders", "Disorders of Gut-Brain Interaction (DGBI)"], "specialty_en": ["Family Practice", "Gastroenterology", "Hospitalist Medicine", "Internal Medicine", "Primary Care"], "chief_complaint_en": ["Abdominal Pain"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["Rome IV Criteria for Functional Biliary Sphincter of Oddi Disorder, Rome IV for Biliary Sphincter of Oddi Disorder, rome iv biliary sphincter of oddi disorder, rome iv biliary sphincter of oddi, rome iv sphincter of oddi disorder, rome iv sphincter of oddi, rome iv biliary sod, biliary sod"], "slug": "rome-iv-diagnostic-criteria-functional-biliary-sphincter-oddi-disorder-sod", "seo": {"meta_description_en": " The Rome IV Criteria for Functional Biliary Sphincter of Oddi Disorder provides criteria for diagnosis of functional biliary sphincter of oddi disorder.", "keywords_en": " Rome IV Criteria for Functional Biliary Sphincter of Oddi Disorder, Rome IV for Biliary Sphincter of Oddi Disorder, rome iv biliary sphincter of oddi disorder, rome iv biliary sphincter of oddi, rome iv sphincter of oddi disorder, rome iv sphincter of oddi, rome iv for biliary pain, rome iv criteria for biliary pain, rome iv biliary sod, biliary sod"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-3e5c0785-7fff-cb31-9507-4221eadf72bf\">Use in patients <strong>post-cholecystectomy</strong> with symptoms characteristic of typical biliary pain as defined by Rome IV criteria with elevated liver enzymes or dilated common bile duct, but NOT both.</p>", "pearls_pitfalls_en": "<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Developed to select patients who would most benefit from biliary sphincterotomy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Advise against using criteria to direct therapy in patients with intact gallbladders without stones.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If pattern not consistent with typical biliary pain, investigate other causes such as <calculator id=\"10002\">functional dyspepsia</calculator> and <calculator id=\"4007\">irritable bowel syndrome</calculator> given risks associated with sphincterotomy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Critical to document objective evidence of elevated liver enzymes during episode and/or dilated bile ducts as their presence/absence can direct significantly different treatments.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Chronic narcotic use can lead to opioid induced hyperalgesia as well as dilated bile ducts, thus clinicians should consider alternative diagnosis in these patients.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Bile duct often dilates post-cholecystectomy due to reservoir effect, though high suspicion if &ge;1 cm.</p>\n</li>\n</ul>", "why_use_en": "<p><span id=\"docs-internal-guid-2c382573-7fff-776c-6397-26cd95c2559f\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Helps objectively delineate diagnosis in condition with considerable controversy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May help direct extremely different treatment strategies (e.g. sphincterotomy versus neuromodulation).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Provides guidance for patient selection in important shared decision-making conversations with patients on potentially high-risk procedures such as sphincterotomy.</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<p dir=\"ltr\">If typical biliary pain + elevated liver enzymes during episode AND bile duct dilation = <strong>definite evidence of biliary obstruction</strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">:<strong style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">&nbsp;</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Formerly SOD type I.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Highest benefit from sphincterotomy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">SOD manometry not needed given false negatives.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If on chronic narcotics, could perform initial endoscopic ultrasound to assess for stones/ampullary pathology prior to sphincterotomy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Patients are at high risk for post-ERCP pancreatitis and thus advise prophylactic temporary pancreatic stent and use of rectal indomethacin since these can substantially reduce risk.<span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">&nbsp;</p>\n</li>\n</ul>\n<p dir=\"ltr\">If typical biliary pain + elevated liver enzymes during episode OR bile duct dilation = <strong>suspected biliary obstruction</strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">:<strong style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">&nbsp;</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Formerly SOD type II.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Controversial role for sphincterotomy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Best role for SOD manometry if available as can predict response to sphincterotomy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Empiric sphincterotomy without manometry found to be cost effective compared to manometry directed sphincterotomy (at the expense of additional procedural risk).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If the expertise is available, could consider botulinum toxin injection into sphincter of Oddi complex to predict clinical response to sphincterotomy (approach not validated).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Non-invasive methods exist (magnetic resonance pancreaticocholangiography, hepatobiliary scintigraphy, fatty meal ultrasound) but are not validated.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider neuromodulation (e.g. amitriptyline, duloxetine) or drugs which can lower SOD pressures (e.g. nifedipine, phosphodiesterase type-5 inhibitors, etc) but not validated.</p>\n</li>\n</ul>\n<p dir=\"ltr\">If classic biliary pain + normal liver enzymes during episode AND normal bile ducts = <strong>functional biliary pain</strong>:</p>\n<p><span id=\"docs-internal-guid-ed329835-7fff-40ae-688c-ccf0c1fc3879\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Formerly SOD type III.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Advise against sphincterotomy (with or without manometry) given lack of benefit over placebo in sham-controlled trials.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Reconsider alternative diagnoses such as centrally mediated abdominal pain syndrome.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Strongly consider neuromodulation (e.g. amitriptyline, duloxetine) or less validated transcutaneous electrical nerve stimulation (TENS) or acupuncture.</p>\n</li>\n</ul>", "management_en": "", "critical_actions_en": "<p dir=\"ltr\">This calculator should primarily be used in patients post-cholecystectomy with low clinical suspicion for structural disease with adequate evaluation including liver and pancreatic enzymes, ultrasound and endoscopic ultrasound, or cross-sectional imaging such as magnetic resonance cholangiopancreatography if clinically indicated.<span id=\"docs-internal-guid-4d3f9e88-7fff-c9a1-cc9e-4ea714c9dc45\"></p>\n<p dir=\"ltr\">NOTE: other GI conditions such as centrally mediated abdominal pain syndrome, irritable bowel syndrome, and functional dyspepsia may coexist with biliary SOD.</p>"}, "about": {"formula_en": "<p>To fulfill the Rome IV criteria for biliary sphincter of Oddi disorder, patient must have the following:</p>\n<ol>\n<li>Criteria for <calculator id=\"10319\">biliary pain</calculator>.</li>\n<li>Elevated liver enzymes&nbsp;OR dilated bile duct, but not both.</li>\n<li>Absence of bile duct stones or other structural abnormalities.</li>\n</ol>\n<p>Supportive criteria:</p>\n<ol>\n<li>Normal amylase/lipase.</li>\n<li>Abnormal sphincter of Oddi manometry.</li>\n<li>Hepatobiliary scintigraphy.</li>\n</ol>", "more_info_en": "<p><img src=\"https://cdn-web-img.mdcalc.com/content/rome_biliary.png\" width=\"100%\" /></p>\n<p>From <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27144629\" target=\"_blank\">Cotton 2020</a>.</p>", "evidence_based_medicine_en": "<p><span id=\"docs-internal-guid-dc039cfc-7fff-38be-71fa-314e478b864c\">One of the landmark trials in evaluating the role for sphincterotomy in patients with possible SOD is the EPISOD trial published in 2014. This multi-center, sham-controlled randomized trial involving 214 patients with pain after cholecystectomy but without lab or imaging abnormalities (formerly SOD type III) demonstrated that there was no benefit for sphincterotomy versus sham treatment. This lack of treatment effect from sphincterotomy persisted at 5 year follow up.&nbsp; </p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/27144629", "text": "Cotton PB, Elta GH, Carter CR, Pasricha PJ, Corazziari ES. Rome IV. Gallbladder and Sphincter of Oddi Disorders. Gastroenterology. 2016;150:1420-1429."}], "Other References": [{"href": "https://pubmed.ncbi.nlm.nih.gov/24867013/", "text": "Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA 2014; 311: 2101\u20132109."}, {"href": "https://pubmed.ncbi.nlm.nih.gov/28455162/", "text": "Cotton PB, Pauls Q, Keith J, et al. The EPISOD study: long-term outcomes. Gastrointest Endosc. 2018;87(1):205-210."}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/29134969", "text": "Aziz I, Palsson OS, T\u00f6rnblom H, Sperber AD, Whitehead WE, Simr\u00e9n M. The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries. Am J Gastroenterol. 2018;113(1):86-96."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"name": "Justin Brandler, MD"}]}, "creator": [{"name": "Dr. Douglas Drossman", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Douglas Drossman, MD, is professor emeritus of medicine and psychiatry at the University of North Carolina School of Medicine. He is founder, President Emeritus and Chief of Operations of the Rome Foundation. He is also the founder of the Drossman Center for the Education and Practice of Biopsychosocial Care and Drossman Consulting, LLC. Dr. Drossman has written over 500 articles and book chapters, has published two books, a GI procedure manual and a textbook of functional GI disorders (Rome I-IV), and serves on six editorial and advisory boards.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-douglas-drossman.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Drossman+DA%5BAuthor%5D"}}, {"name": "Dr. Lin Chang", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Lin Chang, MD is responsible for the oversight and coordination of the Rome IV calculators on MDCalc. She is a Professor of Medicine at the Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA and is a member of the Rome Foundation Board of Directors.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-lin-chang.jpg", "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Chang+L+%5Bauthor%5D"}}, {"name": "The Rome Foundation", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>The <a href=\"https://theromefoundation.org\" target=\"_blank\" rel=\"noopener\">Rome Foundation</a> is an independent not for profit 501(c) 3 organization that provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of Disorders of Gut-Brain Interaction (DGBI), also known as functional gastrointestinal (GI) disorders. Their mission is to improve the lives of people with DGBI. Over the last 3 decades, the Rome organization has sought to legitimize and update our knowledge of the DGBIs. This has been accomplished by bringing together scientists and clinicians from around the world to classify and critically appraise the science of GI function and dysfunction. This knowledge permits clinical scientists to make recommendations for diagnosis and treatment that can be applied in research and clinical practice. Diagnosis is based on the use of <a href=\"https://theromefoundation.org/rome-iv/rome-iv-criteria/\" target=\"_blank\" rel=\"noopener\">symptom-based criteria</a> which are used in clinical trials and daily practice. The list of Rome IV categories and the Chair and Co-Chair of each chapter committee are listed below.</p>\n<table border=\"\\&quot;0\\&quot;\" collapse;=\"\" width:=\"\" 100%;\\\"=\"\">\n<tbody>\n<tr>\n<td 31.1628%;\\\"=\"\"><strong>Committees</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Chair</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Co-Chair</strong></td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Esophageal Disorders</td>\n<td 31.3097%;\\\"=\"\">Ronnie Fass, MD</td>\n<td 31.3097%;\\\"=\"\">John Pandolfino, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gastroduodenal Disorders</td>\n<td 31.3097%;\\\"=\"\">Nicholas J. Talley, MD, PhD, FRACP</td>\n<td 31.3097%;\\\"=\"\">Vincenzo Stanghellini, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Bowel Disorders</td>\n<td 31.3097%;\\\"=\"\">Fermin Mearin, MD</td>\n<td 31.3097%;\\\"=\"\">Brian Lacy, MD, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gallbladder and Sphincter of Oddi Disorders</td>\n<td 31.3097%;\\\"=\"\">Grace Elta, MD</td>\n<td 31.3097%;\\\"=\"\">Peter Cotton, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Centrally Mediated Disorders of Gastrointestinal Pain</td>\n<td 31.3097%;\\\"=\"\">Peter J. Whorwell, MD</td>\n<td 31.3097%;\\\"=\"\">Laurie Keefer, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Anorectal Disorders</td>\n<td 31.3097%;\\\"=\"\">Adil E. Bharucha, MD, MBBS</td>\n<td 31.3097%;\\\"=\"\">Satish S. C. Rao, MD, PhD, FRCP</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Neonate/Toddler</td>\n<td 31.3097%;\\\"=\"\">Sam Nurko, MD</td>\n<td 31.3097%;\\\"=\"\">Marc A. Benninga, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Child/Adolescent</td>\n<td 31.3097%;\\\"=\"\">Carlo Di Lorenzo, MD</td>\n<td 31.3097%;\\\"=\"\">Jeffrey S. Hyams, MD</td>\n</tr>\n</tbody>\n</table>\n<p><b>Rome IV Diagnostic Criteria Chapters, Chairs and Co-Chairs</b></p>\n<p><b>Rome IV Editorial Board:</b> Douglas A. Drossman, MD, Senior Editor, Lin Chang, MD, William D. Chey, MD, John Kellow, MD, Jan Tack, MD, PhD, and William E. Whitehead, PhD.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/rome-foundation.png", "pubmedLink": "undefined"}}], "reviewer": {"expert_name": [{"name": "Jan Track, MD, PhD, RFF"}]}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"subheading": "Must have the following:", "subheading_instructions": "", "type": "subheading"}, {"type": "toggle", "label_en": "Criteria for <calculator id=\"10319\">biliary pain</calculator>", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "one"}, {"type": "toggle", "label_en": "Elevated liver enzymes OR dilated bile duct, but not both", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "two"}, {"type": "toggle", "label_en": "Absence of bile duct stones or other structural abnormalities", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "three"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 10312, "short_title_en": "Rome IV for Pancreatic SOD", "slug": "rome-iv-diagnostic-criteria-functional-pancreatic-sphincter-oddi-disorder-sod"}, {"calcId": 10319, "short_title_en": "Rome IV for Biliary Pain", "slug": "rome-iv-diagnostic-criteria-biliary-pain"}, {"calcId": 10320, "short_title_en": "Rome IV for Gallbladder Disorder", "slug": "rome-iv-diagnostic-criteria-functional-gallbladder-disorder"}]}